Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report

Darren B. Taichman, Joe Ornelas*, Lorinda Chung, James R. Klinger, Sandra Lewis, Jess Mandel, Harold I. Palevsky, Stuart Rich, Namita Sood, Erika B. Rosenzweig, Terence K. Trow, Rex Yung, C. Gregory Elliott, David B. Badesch

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

210 Scopus citations


OBJECTIVE: Choices of pharmacologic therapies for pulmonary arterial hypertension (PAH) are ideally guided by high-level evidence. The objective of this guideline is to provide clinicians advice regarding pharmacologic therapy for adult patients with PAH as informed by available evidence. METHODS: This guideline was based on systematic reviews of English language evidence published between 1990 and November 2013, identified using the MEDLINE and Cochrane Library databases. The strength of available evidence was graded using the Grades of Recommendations, Assessment, Development, and Evaluation methodology. Guideline recommendations, or consensus statements when available evidence was insufficient to support recommendations, were developed using a modified Delphi technique to achieve consensus. RESULTS: Available evidence is limited in its ability to support high-level recommendations. Therefore, we draft ed consensus statements to address many clinical questions regarding pharmacotherapy for patients with PAH. A total of 79 recommendations or consensus statements were adopted and graded. CONCLUSIONS: Clinical decisions regarding pharmacotherapy for PAH should be guided by high-level recommendations when sufficient evidence is available. Absent higher level evidence, consensus statements based upon available information must be used. Further studies are needed to address the gaps in available knowledge regarding optimal pharmacotherapy for PAH.

Original languageEnglish (US)
Pages (from-to)449-475
Number of pages27
Issue number2
StatePublished - Aug 2014

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report'. Together they form a unique fingerprint.

Cite this